MedPath

H. J. Harkins Company, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

207

FDA:207

Drug Approvals

NAPROXEN

Approval Date
Jan 26, 2023
FDA

ESOMEPRAZOLE MAGNESIUM

Approval Date
Dec 27, 2019
FDA

ROSUVASTATIN CALCIUM

Approval Date
Dec 26, 2019
FDA

TIMOLOL MALEATE

Approval Date
Sep 17, 2019
FDA

OLOPATADINE HYDROCHLORIDE

Approval Date
Aug 29, 2019
FDA

VALACYCLOVIR HYDROCHLORIDE

Approval Date
Aug 7, 2019
FDA

TADALAFIL

Approval Date
Jun 28, 2019
FDA

FLOVENT

Approval Date
Apr 30, 2019
FDA

ALBUTEROL SULFATE

Approval Date
Apr 26, 2019
FDA

ALBUTEROL SULFATE

Approval Date
Apr 24, 2019
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.